Suppr超能文献

亚急性甲状腺炎。是否存在长期激素替代治疗的预测因素?

Thyroiditis de Quervain. Are there predictive factors for long-term hormone-replacement?

作者信息

Schenke S, Klett R, Braun S, Zimny M

机构信息

Department of Nuclear Medicine, Klinikum Hanau, Germany.

出版信息

Nuklearmedizin. 2013;52(4):137-40. doi: 10.3413/Nukmed-0536-12-10. Epub 2013 May 7.

Abstract

BACKGROUND

Subacute thyroiditis is a usually self-limiting disease of the thyroid. However, approximately 0.5-15% of the patients require permanent thyroxine substitution. Aim was to determine predictive factors for the necessity of long-term hormone-replacement (LTH).

PATIENTS, METHODS: We retrospectively reviewed the records of 72 patients with subacute thyroiditis. Morphological and serological parameters as well as type of therapy were tested as predictive factors of consecutive hypothyroidism.

RESULTS

Mean age was 49 ± 11 years, f/m-ratio was 4.5 : 1. Thyroid pain and signs of hyperthyroidism were leading symptoms. Initial subclinical or overt hyperthyroidism was found in 20% and 37%, respectively. Within six months after onset 15% and 1.3% of the patients developed subclinical or overt hypothyroidism, respectively. At latest follow-up 26% were classified as liable to LTH. At onset the thyroid was enlarged in 64%, and at latest follow-up in 8.3%, with a significant reduction of the thyroid volume after three months. At the endpoint the thyroid volume was less in patients in the LTH group compared with the non-LTH group (41.7% vs. 57.2% of sex-adjusted upper norm, p = 0.041). Characteristic ultrasonographic features occurred in 74% of the patients in both lobes. Serological and morphological parameters as well as type of therapy were not related with the need of LTH.

CONCLUSIONS

In this study the proportion of patients who received LTH was 26%. At the endpoint these patients had a lower thyroid volume compared with euthyroid patients. No predictive factors for LTH were found.

摘要

背景

亚急性甲状腺炎是一种通常具有自限性的甲状腺疾病。然而,约0.5% - 15%的患者需要长期甲状腺素替代治疗。目的是确定长期激素替代治疗(LTH)必要性的预测因素。

患者与方法

我们回顾性分析了72例亚急性甲状腺炎患者的病历。将形态学和血清学参数以及治疗类型作为持续性甲状腺功能减退的预测因素进行检测。

结果

平均年龄为49±11岁,女性与男性比例为4.5∶1。甲状腺疼痛和甲亢症状是主要症状。分别有20%和37%的患者初发时存在亚临床或显性甲亢。发病后6个月内,分别有15%和1.3%的患者出现亚临床或显性甲状腺功能减退。在最后一次随访时,26%的患者被归类为需要长期激素替代治疗。发病时64%的患者甲状腺肿大,在最后一次随访时为8.3%,3个月后甲状腺体积显著减小。在终点时,长期激素替代治疗组患者的甲状腺体积低于非长期激素替代治疗组(按性别调整后的正常上限的41.7%对57.2%,p = 0.041)。74%的患者双侧叶均出现特征性超声表现。血清学和形态学参数以及治疗类型与长期激素替代治疗的需求无关。

结论

在本研究中,接受长期激素替代治疗的患者比例为26%。在终点时,这些患者的甲状腺体积低于甲状腺功能正常的患者。未发现长期激素替代治疗的预测因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验